Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
40757578	bm-flt3-d	— (—)	133	138	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Myeloid leukaemia

112

+∞

119.07

1.0

0.0

—

Acute myeloid leukaemia and myelodysplastic syndromes

+∞

102.99

1.0

0.0

—

Acute myeloid leukaemia

+∞

101.53

1.0

0.0

—

Acute myeloid leukaemia, including Hilmo

+∞

101.53

1.0

0.0

—

Acute myeloid leukaemia, helper endpoint

+∞

101.53

1.0

0.0

—

Fever of other and unknown origin

17.08

71.89

1.0

1.1

—

Other diseases of blood and blood-forming organs, wide

22.28

69.42

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

13.02

68.47

1.0

—

Bacterial infection, other or unspecified

17.18

66.46

1.0

1.1

—

Other bacterial diseases

12.64

65.89

1.0

—

Bacterial infection, other or unspecified, including avohilmo

14.30

59.76

1.0

1.1

—

Septicaemia

17.91

59.54

1.0

1.1

—

Any event in cancer register

88.83

56.39

1.1

1.0

—

Other septicaemia, including avohilmo

16.99

54.55

1.0

1.1

—

Other bacterial diseases, including avohilmo

10.89

53.64

1.0

—

Other septicaemia

16.35

51.40

1.0

1.1

—

Any death

12.56

50.62

1.0

—

Explicit Sepsis, including avohilmo

11.40

49.39

1.0

1.1

—

Explicit Sepsis

11.03

46.70

1.0

1.1

—

Leukaemia of unspecified cell type

+∞

34.97

1.1

0.0

—

Aplastic and other anaemias

8.59

34.01

1.1

1.0

—

Transplanted organ and tissue status

37.31

29.27

1.0

1.1

—

Other and unspecified anaemias

7.80

27.64

1.1

1.0

—

Other anaemias

7.77

27.54

1.1

1.0

—

Agranulocytosis

31.11

25.88

1.0

—

Other medical care

7.30

25.55

1.0

—

Myelodysplastic syndrome, including Hilmo

+∞

22.99

1.0

0.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

5.05

20.91

1.0

—

Anaemias

+∞

20.88

1.1

0.0

—

General symptoms and signs

6.44

20.10

1.1

—

ILD medications

4.86

19.79

1.0

1.1

—

ILD medications: immunosuppressive drugs

5.68

19.41

1.0

1.1

—

Pneumonia, organism unspecified

4.51

17.68

1.0

—

Certain infectious and parasitic diseases

6.56

17.26

1.0

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

4.45

16.00

1.0

1.1

—

Influenza and pneumonia

4.11

15.89

1.0

—

Any gastric operation

16.16

15.07

1.0

—

GASTRO-related operations

16.16

15.07

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

4.01

14.93

1.0

—

Thrombocytopenia, unspecified

31.84

14.79

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

4.06

14.73

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

+∞

14.59

1.0

0.0

—

All pneumoniae

3.96

14.58

1.0

—

4.41

14.53

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

4.41

14.53

1.0

—

First line medication for Crohn's disease

4.03

14.14

1.0

1.1

—

Purpura and other haemorrhagic conditions

15.77

13.89

1.0

1.1

—

Infections, IBD-co-morbidities

7.39

12.48

1.0

1.1

—

Bacterial Sepsis

5.24

12.19

1.0

1.1

—

Certain infectious and parasitic diseases, including avohilmo

6.44

12.14

1.0

1.1

—

Lymphoid leukaemia

26.83

12.04

1.1

1.0

—

Complications of medical and surgical care

3.93

12.02

1.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

10.02

11.95

1.0

1.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

18.96

11.57

1.0

—

Myelodysplastic syndrome

+∞

11.50

1.1

0.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4.05

11.38

1.0

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

5.01

10.34

1.1

1.0

—

Drug-induced neutropenia

18.84

10.25

1.1

1.0

—

Caries of dentine

8.17

10.22

1.1

—

Malignant neoplasm of digestive organs, including Hilmo

+∞

10.14

1.0

0.0

—

Oxycodone

4.67

10.05

1.0

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

3.60

10.03

1.1

1.0

—

L04AD Calcineurin inhibitors

10.62

9.76

1.0

—

Dental caries

7.16

9.42

1.1

—

Malignant neoplasm of digestive organs

+∞

9.37

1.0

0.0

—

Persons encountering health services for specific procedures and health care

3.06

8.68

1.0

1.1

—

Other/unspecified cytomegaloviral diseases

+∞

8.35

1.0

0.0

—

Secondary uncertain malignant neoplasm

+∞

8.33

1.0

0.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

+∞

8.33

1.0

0.0

—

Complications of surgical and medical care, not elsewhere classified

2.95

7.89

1.0

1.1

—

Enlarged lymph nodes

13.02

7.86

1.0

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes

+∞

7.29

1.0

0.0

—

Inflammatory bowel disease treatment related agents

2.68

7.01

1.0

1.1

—

Non-follicular lymphoma

13.78

6.88

1.0

—

malignant neoplasm of male genital organs, including Hilmo

+∞

6.76

1.0

0.0

—

Myeloproliferative diseases

16.71

6.74

1.0

—

Viral infections characterized by skin and mucous membrane lesions

3.70

6.61

1.0

1.1

—

Explicit bacterial Sepsis

11.02

6.29

1.1

—

Explicit bacterial Sepsis, including avohilmo

11.02

6.29

1.1

—

Myeloproliferative diseases (CML excluded)

18.05

6.26

1.0

—

Non-Hodgkin lymphoma, all

+∞

6.25

1.0

0.0

—

Malignant neoplasm of skin, including Hilmo

+∞

6.20

1.0

0.0

—

Covid-19 confirmed case

3.95

6.14

1.0

1.1

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

+∞

6.09

1.1

0.0

—

Malignant neoplasm of breast, including Hilmo

+∞

6.09

1.1

0.0

—

malignant neoplasm of male genital organs

+∞

5.92

1.0

0.0

—

Malignant neoplasm of prostate, including Hilmo

+∞

5.87

1.0

0.0

—

COPD/asthma related infections

2.81

5.69

1.1

1.0

—

COPD/asthma/ILD related infections

2.81

5.69

1.1

1.0

—

Acute upper respiratory infections

2.56

5.56

1.1

1.0

—

Other viral diseases, including avohilmo

3.50

5.50

1.0

1.1

—

Bronchitis

2.46

5.48

1.1

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

+∞

5.35

1.0

0.0

—

Malignant neoplasm of skin

+∞

5.34

1.0

0.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

+∞

5.33

1.0

0.0

—

Monocytic leukaemia

+∞

5.24

1.0

0.0

—

Malignant neoplasm of breast, HER2-negative

+∞

5.23

1.2

0.0

—

Malignant neoplasm of breast

+∞

5.23

1.2

0.0

—

Essential (haemorrhagic) thrombocythaemia

+∞

5.21

1.0

0.0

—

Recurrent aphthous stomatitis , including avohilmo

7.34

5.13

1.0

—

malignant neoplasm of female genital organs, including Hilmo

+∞

5.11

1.0

0.0

—

Mycoses

3.75

5.08

1.1

—

Malignant neoplasm of breast, ER-negative, including Hilmo

+∞

5.08

1.0

0.0

—

Colorectal cancer, including Hilmo

+∞

5.07

1.0

0.0

—

Malignant neoplasm of prostate

+∞

5.04

1.0

0.0

—

Headache

3.74

5.03

1.0

1.1

—

Gastrointestinal diseases

3.76

4.88

1.0

—

Implicit bacterial Sepsis

3.52

4.77

1.0

1.1

—

Erysipelas

4.46

4.67

1.0

1.1

—

Malignant neoplasm of breast, HER-positive

+∞

4.63

1.2

0.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

+∞

4.63

1.2

0.0

—

Osteonecrosis

14.03

4.57

1.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

8.19

4.55

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

3.32

4.42

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

100

2.33

4.30

1.0

—

Enterocolitis due to Clostridium difficile

8.90

4.27

1.0

—

Other problems related to primary support group, including family circumstances

7.30

4.26

1.0

—

Implicit bacterial Sepsis, including avohilmo

3.25

4.22

1.0

1.1

—

Erysipelas, including avohilmo

3.20

4.02

1.0

1.1

—

Other bacterial intestinal infections

5.00

4.00

1.0

1.1

—

Bacterial intestinal infections, IBD co-morbidities

5.00

3.99

1.0

1.1

—

Certain disorders involving the immune mechanism

4.45

3.93

1.0

1.1

—

Persons encountering health services for examination and investigation

3.11

3.83

1.1

1.0

—

Other metabolic disorders

6.01

3.81

1.0

—

2.18

3.79

1.1

1.0

—

Abnormal findings on diagnostic imaging of lung

2.75

3.75

1.1

1.0

—

COPD differential diagnosis

2.69

3.71

1.1

1.0

—

ILD differential diagnosis

2.69

3.71

1.1

1.0

—

Herpesviral [herpes simplex] infections

5.63

3.65

1.0

—

Candidiasis

5.63

3.65

1.1

1.0

—

Bleeding

2.23

3.59

1.1

1.0

—

Polyneuropathies and other disorders of the peripheral nervous system

4.00

3.59

1.0

1.1

—

Other viral diseases

3.49

3.58

1.0

1.1

—

Stomatitis and related lesions

4.23

3.50

1.0

—

Acute pharyngitis

5.24

3.47

1.0

1.1

—

Oral corticosteroids

2.14

3.46

1.0

1.1

—

Medical observation and evaluation for suspected diseases and conditions

3.00

3.46

1.0

—

Other pulmonary diagnosis

2.56

3.43

1.1

1.0

—

Excluding asthma or asthma-COPD overlap

2.56

3.43

1.1

1.0

—

Bacterial pneumonia (organism specified)

2.70

3.41

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

2.51

3.39

1.0

1.1

—

Codes for special purposes

2.51

3.39

1.0

1.1

—

Other bacterial intestinal infections, including avohilmo

4.08

3.39

1.0

1.1

—

Zoster [herpes zoster], including avohilmo

2.51

3.37

1.0

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

2.26

3.26

1.0

1.1

—

5.34

3.19

1.0

—

Implicit Sepsis, including avohilmo

2.42

3.10

1.0

1.1

—

Other skin changes

4.00

3.08

1.0

—

DVT of lower extremities and pulmonary embolism

2.67

3.02

1.1

—

Candidiasis, including avohilmo

3.24

2.92

1.1

—

Zoster [herpes zoster]

3.71

2.87

1.0

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

3.66

2.84

1.0

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.18

2.83

1.0

—

Other acute lower respiratory infections

2.42

2.81

1.0

1.1

—

Oedema, not elsewhere classified

4.00

2.81

1.0

—

Venous thromboembolism

2.34

2.80

1.1

—

Intestinal infectious diseases

105

1.98

2.78

1.0

—

Other infectious diseases

8.34

2.75

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

8.34

2.75

1.0

—

Malaise and fatigue

3.15

2.75

1.2

1.1

—

Thoracic aortic aneurysm

5.00

2.72

1.1

—

Retinal detachments and breaks

2.71

1.1

1.0

—

Implicit Sepsis

2.33

2.62

1.0

1.1

—

Heart failure and bmi 25plus

2.80

2.61

1.1

1.0

—

Herpesviral [herpes simplex] infections, including avohilmo

3.34

2.60

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.67

2.56

1.1

—

Chronic apical periodontitis

1.89

2.55

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.23

2.50

1.0

1.1

—

Pulmonary embolism

2.97

2.48

1.0

1.1

—

Pulmonary heart disease

2.97

2.48

1.0

1.1

—

Aortic aneurysm

3.39

2.42

1.1

1.0

—

Other infectious diseases, including avohilmo

6.26

2.37

1.0

—

Personal history of other diseases and conditions

6.22

2.36

1.0

—

Viral pneumonia

4.12

2.36

1.0

1.1

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.07

2.33

1.1

1.0

—

Other diseases of intestines

1.84

2.30

1.1

1.0

—

Pulmonary heart disease, diseases of pulmonary circulation

2.75

2.27

1.0

1.1

—

All kidney diseases

1.86

2.26

1.0

1.1

—

All influenza

3.10

2.22

1.0

1.1

—

Metabolic disorders

1.86

2.20

1.0

—

Other viral diseases, not elsewhere classified, including avohilmo

2.84

2.18

1.0

1.1

—

Disorders of tooth development and eruption

4.44

2.14

1.0

1.1

—

Convulsions, not elsewhere classified

3.95

2.01

1.0

1.1

—

Disorders of choroid and retina

1.87

1.99

1.1

1.0

—

Procreative management

2.33

1.98

1.1

—

L04AX Other immunosuppressants

2.02

1.94

1.0

1.1

—

Diplopia

3.75

1.93

1.0

1.1

—

Cardiovascular diseases

2.18

1.91

1.0

1.1

—

Mycoses, including avohilmo

107

1.78

1.89

1.0

—

Second line medication for Crohn's disease

2.00

1.89

1.0

1.1

—

Unspecified acute lower respiratory infection

3.18

1.88

1.0

—

Bacterial pneumoniae

2.41

1.83

1.0

1.1

—

Sarcoidosis

3.53

1.83

1.0

—

Myopia

3.53

1.83

1.0

—

Ovarian cyst

0.00

1.79

0.0

1.0

—

Heart failure, not strict

1.82

1.78

1.0

—

Presence of other devices

3.00

1.76

1.0

—

Other diseases of hard tissues of teeth

2.16

1.76

1.0

1.1

—

Pain, not elsewhere classified

3.33

1.74

1.0

1.1

—

Diseases of the eye and adnexa

1.88

1.73

1.1

1.0

—

Asthma (only as main-diagnosis), excluding more controls

2.13

1.73

1.0

—

Intracranial trauma

1.98

1.73

1.1

—

Diseases of the respiratory system

2.15

1.72

1.1

1.0

—

Other and unspecified polyneuropathies, also in other diseases

2.92

1.72

1.0

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

2.03

1.68

1.0

—

Parasetamol

1.92

1.67

1.0

1.1

—

Hydrocele

3.16

1.66

1.0

1.1

—

Implicit viral Sepsis

3.16

1.66

1.0

1.1

—

Viral Sepsis

3.16

1.66

1.0

1.1

—

Disorders of eyelid, lacrimal system and orbit

1.74

1.63

1.0

1.1

—

Dental operations

2.08

1.63

1.0

1.1

—

Pain associated with micturition

3.57

1.61

1.2

1.1

—

Other female pelvic inflammatory diseases

3.57

1.61

1.0

1.1

—

Coxibs

0.00

1.60

0.0

1.1

—

Bacterial pneumonia, not elsewhere classified

2.37

1.60

1.0

1.1

—

Asthma (only as main-diagnosis)

2.04

1.59

1.0

—

Other arrhythmias

1.89

1.58

1.1

1.0

—

Diseases of oesophagus, stomach and duodenum

1.66

1.58

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1.87

1.58

1.0

—

Heart failure,strict

1.97

1.54

1.1

1.0

—

Mixed conductive and sensorineural hearing loss

3.34

1.52

1.0

1.1

—

Care involving use of rehabilitation procedures

1.93

1.52

1.0

1.1

—

Visual disturbances

1.94

1.48

1.0

1.1

—

Renal tubulo-interstitial diseases

1.70

1.46

1.0

1.1

—

Viral and other specified intestinal infections

2.79

1.46

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

2.50

1.45

1.1

—

Fissure and fistula of anal and rectal regions

2.50

1.45

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.99

1.45

1.1

1.0

—

Gout, FINNGEN

2.35

1.44

1.0

1.1

—

Viral and other specified intestinal infections, including avohilmo

2.49

1.44

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.66

1.44

1.0

1.1

—

severe traumatic brain injury, does not include concussion

2.73

1.43

1.0

1.1

—

Early onset COPD, excluding more controls

2.73

1.43

1.0

—

COPD (mode)

2.34

1.43

1.1

1.0

—

Other heart diseases, wide

1.68

1.42

1.1

1.0

—

Other disorders of patella

2.61

1.36

1.0

1.2

—

Gout

2.21

1.36

1.0

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

2.61

1.35

1.0

—

Non-allergic asthma (mode)

2.91

1.34

1.0

1.1

—

Acute sinusitis

1.98

1.33

1.0

—

Heart failure and antihypertensive medication

2.47

1.32

1.1

1.0

—

Sleep disorders (combined)

103

0.51

1.30

1.0

—

Infections of the skin and subcutaneous tissue

1.77

1.30

1.0

1.1

—

Asthma

1.89

1.30

1.1

1.0

—

Cellulitis

2.35

1.29

1.0

1.1

—

Other disorders of the musculoskeletal system and connective tissue

2.78

1.28

1.0

1.1

—

Non-allergic asthma (mode), excluding more controls

2.75

1.27

1.0

1.1

—

Traumatic subdural haemorrhage

2.75

1.26

1.0

1.1

—

Injuries to the knee and lower leg

119

0.54

1.26

1.1

1.0

—

Visual disturbances and blindness

1.82

1.24

1.0

1.1

—

Non-invasive ventilation

2.23

1.23

1.0

—

Dermatitis and eczema

104

1.54

1.22

1.0

—

Impacted teeth

2.68

1.22

1.0

—

Retinal breaks without detachment

2.63

1.21

1.0

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.21

1.21

1.1

—

Diabetes mellitus in pregnancy

0.00

1.20

0.0

1.0

—

False labour

0.00

1.19

0.0

1.0

—

Diseases of the skin and subcutaneous tissue

1.62

1.19

1.0

1.1

—

Preterm labour and delivery

2.31

1.18

1.0

—

Angina pectoris

1.78

1.17

1.1

1.0

—

Sleep disorders

106

0.52

1.17

1.0

—

Seropositive rheumatoid arthritis

0.00

1.16

0.0

1.1

—

Otitis externa

0.00

1.16

0.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

0.00

1.16

0.0

1.1

—

Other/unspecified seropositive rheumatoid arthritis

0.00

1.16

0.0

1.1

—

Asthma, excluding more controls

1.84

1.15

1.1

1.0

—

Other condition

2.50

1.15

1.2

1.0

—

Atrial fibrillation and flutter with reimbursement

2.10

1.15

1.3

1.1

—

Seropositive rheumatoid arthritis, wide

0.00

1.14

0.0

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

103

0.44

1.13

1.0

—

Conjunctivitis (acute, non atopic)

1.99

1.11

1.3

1.0

—

Heart failure, strict

1.74

1.11

1.1

1.0

—

Other and unspecified disorders of vitreous body

1.83

1.10

1.2

1.0

—

Diagnoses used for exclusion with ILD

2.26

1.10

1.0

1.1

—

Presence of other functional implants

1.82

1.10

1.1

1.0

—

Other diseases of lip and oral mucosa

1.82

1.08

1.1

—

Asthma (mode)

1.79

1.08

1.1

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.72

1.07

1.0

1.1

—

Atrial fibrillation and flutter

2.07

1.07

1.1

—

Diseases of the digestive system

1.80

1.06

1.0

—

Conjunctivitis (acute, non atopic), including avohilmo

1.51

1.03

1.1

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.74

1.03

1.0

1.1

—

DVT of lower extremities

2.27

1.03

1.2

1.1

—

Urolithiasis

1.96

1.03

1.0

—

D07AA Corticosteroids, weak (group I)

2.27

1.03

1.0

—

Neurological diseases, wide definition

2.01

1.03

1.0

—

Colonic or urogenital fistula

2.06

1.02

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.65

1.02

1.1

1.0

—

Acute suppurative otitis media

2.04

1.01

1.0

—

Other disorders of lacrimal gland

1.89

1.01

1.0

1.1

—

Acute bronchitis

1.89

1.00

1.0

1.1

—

Disorders of thyroid, IBD co-morbidities

0.00

1.00

0.0

1.1

—

Examination and observation for other reasons

1.94

0.98

1.0

—

Superficial injury of thorax

2.17

0.98

1.0

—

Cholecystectomy

1.62

0.97

1.0

1.1

—

Benzodiazepine use

104

1.49

0.97

1.0

—

Thyrotoxicosis

0.00

0.97

0.0

1.0

—

Heart failure and coronary heart disease

1.83

0.97

1.1

1.0

—

Other and unspecified dermatitis

1.69

0.95

1.0

1.1

—

Disorders of lacrimal system

1.77

0.93

1.0

1.1

—

Acute and subacute iridocyclitis

2.22

0.93

1.3

1.0

—

Chronic periodontitis, complicated

1.64

0.93

1.0

1.1

—

Other viral diseases, not elsewhere classified

2.14

0.91

1.0

—

Dermatitis

1.59

0.89

1.0

1.1

—

Anterior Iridocyclitis

2.07

0.89

1.3

1.0

—

Nausea and vomiting

1.90

0.88

1.0

—

Cough

1.74

0.88

1.1

—

Disease of hard tissues of teeth, NOS

1.74

0.87

1.0

1.1

—

Other diseases of anus and rectum

1.85

0.87

1.0

—

Disorders of refraction and accommodation

1.85

0.87

1.0

—

Other and unspecified nerve root and plexus disorders, also in other diseases

2.00

0.87

1.2

1.1

—

Iridocyclitis

2.00

0.87

1.3

1.0

—

Calculus of kidney and ureter

1.82

0.85

1.0

—

All-cause Heart Failure

1.62

0.85

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

1.58

0.85

1.2

1.0

—

Endocrine, nutritional and metabolic diseases

1.52

0.85

1.1

1.0

—

L04AA Selective immunosuppressants

1.94

0.84

1.0

1.1

—

Haemorrhage from respiratory passages

1.77

0.84

1.0

—

Disorders of vitreous body

1.63

0.84

1.2

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.42

0.83

1.0

—

Antenatal screening

0.00

0.83

0.0

1.1

—

Injury, poisoning and certain other consequences of external causes

1.67

0.82

1.0

—

Injuries to the thorax

1.69

0.82

1.1

—

Implicit viral Sepsis, including avohilmo

1.87

0.81

1.0

1.1

—

Lumbar disc prolapse

1.54

0.81

1.0

1.1

—

Cholelithiasis

1.50

0.80

1.0

1.1

—

Alzheimer’s disease, strict definition

0.00

0.80

0.0

1.1

—

Endometriosis of pelvic peritoneum

0.00

0.79

0.0

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

0.00

0.79

0.0

1.0

—

Injury of eye and orbit

0.00

0.79

0.0

1.1

—

Aneurysms, operations, SAH

0.00

0.79

0.0

1.1

—

Disorders of vitreous body and globe

1.60

0.79

1.2

1.0

—

Gastroduodenal ulcer

1.81

0.78

1.0

1.1

—

Gestational [pregnancy-induced] hypertension

0.00

0.78

0.0

1.0

—

Coxarthrosis, primary

0.50

0.78

1.0

—

Gingivitis and periodontal diseases

1.44

0.77

1.0

1.1

—

Substance use, excluding alcohol

0.00

0.77

0.0

1.0

—

Polyarthrosis

0.00

0.77

0.0

1.2

—

Other soft tissue disorders, not elsewhere classified

1.44

0.76

1.0

—

Injury of muscle and tendon at lower leg level

0.00

0.76

0.0

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

1.43

0.76

1.0

—

Antihypertensive medication - note that there are other indications

1.62

0.75

1.0

—

5-aminosalicylic acid

2.08

0.74

1.0

1.1

—

Disorders of synovium and tendon

1.57

0.74

1.0

1.1

—

Unstable angina pectoris

1.64

0.73

1.1

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.46

0.72

1.0

1.1

—

Cardiomyopathy

2.00

0.72

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

105

0.66

0.72

1.0

—

Insomnia

103

0.61

0.70

1.0

—

Codeine

1.48

0.70

1.1

—

Lower back pain or/and sciatica

114

0.65

0.70

1.0

—

Osteopathies and chondropathies

1.54

0.70

1.0

1.1

—

Other headache syndromes

1.55

0.69

1.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

0.54

0.68

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.53

0.68

1.0

1.1

—

Acute renal failure

1.85

0.68

1.0

1.1

—

Migraine with aura

1.85

0.68

1.0

1.1

—

Pure hypercholesterolaemia

1.46

0.68

1.0

1.1

—

GI-bleeding

1.67

0.68

1.0

—

0.54

0.67

1.4

1.0

—

Other diseases of the digestive system

1.63

0.66

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

0.53

0.66

1.4

1.0

—

Use of pramipexole

1.79

0.66

1.0

1.1

—

Abnormalities of breathing

1.41

0.64

1.0

—

Inguinal hernia

0.58

0.64

1.2

1.0

—

Sequelae with surgical and medical care as external cause

1.72

0.64

1.0

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.39

0.63

1.1

1.0

—

Pain in throat and chest

1.42

0.63

1.1

1.0

—

Open wound of wrist and hand

1.56

0.63

1.1

1.0

—

Dental pulpitis, including avohilmo

0.65

0.63

1.1

1.0

—

Cardiac arrhythmias

1.51

0.62

1.1

—

Other heart diseases

1.62

0.62

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

0.62

0.0

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.63

0.62

1.0

1.1

—

Supervision of high-risk pregnancy

0.00

0.61

0.0

1.1

—

Anomalies of dental arch relationship, including avohilmo

1.67

0.61

1.2

1.0

—

Other CVD (FINNGEN)

0.00

0.61

0.0

1.1

—

External causes of morbidity and mortality

1.47

0.61

1.0

—

Other strabismus

1.66

0.61

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.61

0.0

1.1

—

Childhood allergy (age < 16)

0.00

0.61

0.0

1.0

—

Irregular menses

1.58

0.61

1.0

1.1

—

Exposure to other specified factors

120

0.64

0.61

1.0

—

Lung cancer and mesothelioma

0.00

0.60

0.0

1.1

—

Tumor necrosis factor alpha inhibitors

0.00

0.60

0.0

1.0

—

Unspecified mental disorder

1.57

0.60

1.1

—

Other sleep disorders

0.00

0.60

0.0

1.1

—

Thyrotoxicosis, other and/or unspecified

0.00

0.60

0.0

1.0

—

Pain in limb

1.39

0.59

1.1

1.0

—

Other CVD

0.00

0.59

0.0

1.0

—

Urticaria and erythema

1.54

0.59

1.0

1.1

—

Disorders of parathyroid gland

0.00

0.59

0.0

1.1

—

Other antidepressants

0.67

0.59

1.1

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

0.67

0.58

1.2

1.0

—

Adenomyosis (Endometriosis of uterus)

0.00

0.58

0.0

1.0

—

Hypertension, essential

1.39

0.58

1.2

1.0

—

Finngen Rheumatological endpoints

1.35

0.58

1.0

1.1

—

Psychiatric diseases

0.68

0.58

1.1

1.0

—

Early onset COPD

1.71

0.57

1.0

—

Chronic diseases of tonsils and adenoids

0.66

0.57

1.1

1.0

—

Cervicobrachial syndrome

1.67

0.56

1.0

1.1

—

Low back pain

0.64

0.56

1.0

1.1

—

Necrosis of pulp, including avohilmo

0.55

1.0

1.1

—

Other noninfective gastroenteritis and colitis

1.62

0.55

1.0

1.1

—

L02BG Aromatase inhibitors

1.60

0.55

1.2

1.0

—

Pain (limb, back, neck, head abdominally)

1.40

0.55

1.0

—

COPD related to multimorbidity

1.52

0.55

1.1

1.0

—

Opioids

1.39

0.54

1.0

1.1

—

Cutaneous abscess, furuncle and carbuncle

1.58

0.54

1.0

1.1

—

Disorders of sclera, cornea, iris and ciliary body

1.46

0.54

1.2

1.0

—

Cerebrovascular diseases (FINNGEN)

1.56

0.53

1.2

1.1

—

Asthma (diagnoses ohter than nonallergic)

119

0.68

0.53

1.1

1.0

—

Acute appendicitis

100

1.39

0.53

1.1

1.0

—

Strabismus

1.53

0.53

1.0

1.1

—

Persons encountering health services in circumstances related to reproduction

1.42

0.52

1.1

—

Coronary atherosclerosis

1.42

0.52

1.1

1.0

—

Tramadol

1.43

0.52

1.0

1.1

—

Fall on same level involving ice and snow

0.62

0.52

1.0

1.1

—

Fracture of lower leg, including ankle

0.61

0.51

1.2

1.0

—

Other specified/unspecified arthritis

1.50

0.51

1.0

1.1

—

Obesity

0.59

0.51

1.2

1.0

—

Obesity and other hyperalimentation

0.59

0.51

1.2

1.0

—

Meniscus derangement

1.44

0.51

1.0

1.1

—

Other inflammation of eyelid, including avohilmo

1.38

0.50

1.0

1.1

—

Persons encountering health services in other circumstances, wide

105

0.73

0.50

1.0

—

Type of accident

1.46

0.50

1.2

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.46

0.50

1.2

1.1

—

Schizophrenia, schizotypal and delusional disorders

1.46

0.50

1.2

1.1

—

Concussion

1.47

0.49

1.1

—

Sleep apnoea

106

0.71

0.49

1.0

—

Symptoms and signs involving the digestive system and abdomen

1.29

0.49

1.1

1.0

—

Soft tissue disorders related to use, overuse and pressure

1.52

0.48

1.0

1.1

—

Depression or dysthymia

0.66

0.48

1.0

—

Gonarthrosis,primary

0.69

0.47

1.0

1.1

—

Cardiodefibrillation

1.48

0.47

1.1

1.0

—

Suppurative and unspecified otitis media

1.48

0.47

1.0

—

Noninfective enteritis and colitis

1.47

0.46

1.0

1.1

—

Spinal stenosis

0.59

0.46

1.0

1.1

—

Epilepsy

1.42

0.45

1.0

1.1

—

Fracture at wrist and hand level

1.42

0.45

1.0

1.1

—

Acute tubulo-interstitial nephritis

1.39

0.45

1.0

1.1

—

Transient ischemic attack

1.44

0.45

1.0

—

Nerve, nerve root and plexus disorders

1.29

0.45

1.0

—

Asthma, unspecified (mode), excluding more controls

1.47

0.43

1.1

1.0

—

Chronic lower respiratory diseases

105

1.25

0.43

1.0

—

Embedded and impacted teeth

1.62

0.43

1.0

—

Polyuria

1.61

0.43

1.0

1.1

—

Asthma, unspecified (mode)

1.41

0.42

1.1

1.0

—

Carpal tunnel syndrome

0.63

0.42

1.0

—

Subjective visual disturbances

1.56

0.42

1.0

1.1

—

Nontoxic goitre/thyroid nodule

1.56

0.42

1.2

1.0

—

Open wound of head

0.63

0.42

1.2

1.0

—

Coronary artery bypass grafting

1.54

0.42

1.2

1.0

—

Crowding of teeth, including avohilmo

0.00

0.41

0.0

1.0

—

Prolonged pregnancy

0.00

0.41

0.0

1.0

—

Maternal care for known or suspected fetal abnormality and damage

0.00

0.41

0.0

1.0

—

Labour and delivery complicated by fetal stress [distress]

0.00

0.41

0.0

1.0

—

Phobic anxiety disorders

0.00

0.41

0.0

1.0

—

0.00

0.41

0.0

1.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.41

0.0

1.0

—

Cerebral palsy and other paralytic syndromes

0.00

0.41

0.0

1.0

—

Pedal cyclist injured in other and unspecified transport accidents

0.00

0.41

0.0

1.0

—

HSIL lesion of the cervix uteri

0.00

0.41

0.0

1.0

—

Other disorders of glucose regulation and pancreatic internal secretion

0.00

0.41

0.0

1.0

—

Glomerular disorders in diseases classified elsewhere

0.00

0.41

0.0

1.1

—

Abnormal findings on diagnostic imaging of other body structures

0.00

0.41

0.0

1.1

—

Diseases of the myoneural junction and muscle

0.00

0.40

0.0

1.0

—

Superficial injury of shoulder and upper arm

0.00

0.40

0.0

1.0

—

Peripheral artery disease

1.34

0.40

1.0

—

Hyperparathyroidism

0.00

0.40

0.0

1.1

—

Appendicitis, broad definition

102

1.32

0.40

1.1

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

103

0.75

0.40

1.2

1.0

—

Dyspnoea

101

1.29

0.40

1.0

—

Alcoholic liver disease

0.00

0.40

0.0

1.1

—

Cervical polyps

0.00

0.40

0.0

1.1

—

Disorders of muscles

0.00

0.40

0.0

1.1

—

Chronic pancreatitis

0.00

0.40

0.0

1.1

—

Benign neoplasm: Ascending colon

0.00

0.40

0.0

1.1

—

Hallux rigidus

0.00

0.40

0.0

1.2

—

Other diseases of intestine

0.00

0.40

0.0

1.1

—

Hypotension

0.00

0.40

0.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

109

0.74

0.40

1.1

1.0

—

Diseases of appendix

102

1.31

0.39

1.1

1.0

—

Seborrhoeic keratosis

1.43

0.39

1.0

1.1

—

Functional dyspepsia

1.43

0.39

1.0

1.1

—

Neurological diseases

1.29

0.39

1.1

—

Monoamine oxidase A inhibitors

0.00

0.39

0.0

1.1

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.39

0.0

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

1.34

0.38

1.0

—

Falls/tendency to fall

103

0.78

0.38

1.0

—

Caries of enamel

112

0.76

0.38

1.0

—

Sensorineural hearing loss

1.30

0.38

1.0

—

Other chronic obstructive pulmonary disease

1.34

0.38

1.1

1.0

—

Acute appendicitis, no complications

1.37

0.37

1.2

1.0

—

Sequelae of external causes of morbidity and mortality

1.35

0.37

1.0

1.1

—

Other intervertebral disc disorders

1.28

0.37

1.0

1.1

—

Gonarthrosis [arthrosis of knee](FG)

0.73

0.36

1.0

1.1

—

COPD, early/later onset

1.28

0.36

1.1

1.0

—

Abdominal and pelvic pain

1.24

0.36

1.1

1.0

—

Injuries to the shoulder and upper arm

113

0.75

0.36

1.0

—

Schizophrenia or delusion, excluding more controls

1.44

0.35

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

1.32

0.35

1.1

1.0

—

Mental and behavioural disorders due to alcohol

0.63

0.35

1.4

1.0

—

Schizophrenia or delusion

1.43

0.35

1.2

1.1

—

Chronic kidney disease

1.41

0.35

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.29

0.35

1.1

1.0

—

Diseases of the ear and mastoid process

1.23

0.34

1.0

—

Medicines for HER+ breast cancer

1.36

0.34

1.2

1.0

—

Type 2 diabetes

0.76

0.34

1.2

1.0

—

Melanocytic naevi

1.36

0.34

1.2

1.1

—

Renal failure

1.37

0.34

1.0

—

Caries of dentine, including avohilmo

1.28

0.33

1.1

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

0.67

0.33

1.0

—

Primary gonarthrosis, bilateral

0.69

0.33

1.0

1.1

—

Arthropathies

1.25

0.33

1.0

1.1

—

Injuries to the head

112

0.79

0.32

1.1

1.0

—

Conductive and sensorineural hearing loss

1.26

0.32

1.0

1.1

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.28

0.32

1.2

1.1

—

Kela-code for severe mental illness

1.28

0.32

1.2

1.1

—

Constipation

105

0.77

0.32

1.1

1.0

—

Polycystic ovarian syndrome, consortium definition

1.34

0.31

1.0

—

Intracranial injury

1.29

0.31

1.1

1.0

—

Spontaneous abortion

1.34

0.31

1.0

1.1

—

Gonarthrosis, primary, with knee surgery

0.72

0.31

1.0

1.1

—

Persons with potential health hazards related to communicable diseases

1.33

0.31

1.0

1.1

—

Other dorsopathies, not elsewhere classified

0.78

0.30

1.0

1.1

—

Other/unspecified dorsalgia

1.30

0.30

1.0

1.1

—

Presence of cardiac and vascular implants and grafts

1.29

0.30

1.1

—

Periodontitis

1.22

0.30

1.0

1.1

—

Exposure to unspecified factor

119

0.80

0.30

1.0

—

Asthma-related pneumonia

1.27

0.29

1.0

—

Asthma-related pneumonia or sepsis

1.27

0.29

1.0

—

Asthma, hospital admissions 3, pneumonia

1.27

0.29

1.0

—

Other disorders of eyelid

1.33

0.29

1.0

1.1

—

Type 2 diabetes, strict (exclude DM1)

0.78

0.29

1.2

1.0

—

Internal derangement of knee

1.24

0.29

1.0

1.1

—

Other nutritional deficiencies

0.75

0.29

1.1

1.0

—

Other diseases of urinary system

0.80

0.28

1.0

1.1

—

Chronic periodontitis, including avohilmo

100

1.21

0.28

1.0

—

Hypertensive diseases (excluding secondary)

1.26

0.28

1.0

1.1

—

Triptan medication for migraine, single purchase ok

0.75

0.28

1.0

1.1

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

0.75

0.28

1.0

1.1

—

Disorders of lens

1.26

0.27

1.1

1.0

—

Injuries to the elbow and forearm

1.25

0.27

1.1

1.0

—

Chronic sinusitis

1.25

0.27

1.0

1.1

—

Diabetes mellitus

100

0.81

0.27

1.1

1.0

—

Complications of procedures, not elsewhere classified

1.26

0.27

1.0

1.1

—

Type 2 diabetes, definitions combined

0.79

0.27

1.2

1.0

—

Diabetes medication

101

0.81

0.27

1.1

1.0

—

Dorsalgia

0.80

0.27

1.0

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

1.20

0.27

1.1

1.0

—

Other diseases of pleura

1.22

0.27

1.1

1.0

—

Other disorders of ear

1.21

0.27

1.0

1.1

—

Recurrent or chronic depression

0.69

0.26

1.0

1.1

—

Diabetes, varying definitions

100

0.81

0.26

1.1

1.0

—

Leiomyoma of uterus

1.26

0.26

1.1

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1.26

0.26

1.1

1.0

—

Sleep apnoea, including avohilmo

104

0.81

0.26

1.0

—

Obesity due to excess calories

0.69

0.26

1.2

1.1

—

Valvular heart disease excluding rheumatic fever

1.24

0.25

1.0

—

Other cataract

1.24

0.25

1.1

1.0

—

Non-rheumatic valve diseases

1.23

0.25

1.0

—

COPD

1.24

0.25

1.1

1.0

—

Other (not insulin) diabetes medications

0.80

0.25

1.2

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.27

0.25

1.2

1.0

—

Gastro-oesophageal reflux disease

1.25

0.25

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.21

0.25

1.1

1.0

—

Periapical abscess

1.20

0.25

1.0

1.1

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.18

0.24

1.1

—

Cystitis

0.80

0.24

1.0

—

Migraine

0.71

0.24

1.0

1.1

—

Diabetic retinopathy

1.35

0.24

1.2

1.0

—

Psoriasis

1.32

0.23

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1.24

0.23

1.1

1.0

—

Mood disorders

108

0.83

0.23

1.0

—

Ventral hernia

1.28

0.23

1.0

1.1

—

Combinations of oral blood glucose lowering drugs

1.28

0.23

1.0

1.1

—

All anxiety disorders

0.73

0.22

1.1

—

Mood [affective] disorders

108

0.83

0.22

1.0

—

Anxiety (asthma-related co-morbidities)

0.73

0.22

1.1

1.0

—

Anxiety disorders

1.19

0.22

1.1

1.0

—

Impingement syndrome of shoulder

1.22

0.22

1.0

1.1

—

Childhood asthma (age<16), excluding more controls

0.00

0.22

0.0

1.0

—

Childhood asthma (age<16)

0.00

0.22

0.0

1.0

—

Dermatitis due to ingested food

0.00

0.21

0.0

1.0

—

Dementia in Alzheimer disease

0.00

0.21

0.0

1.0

—

Unspecified/other endometriosis

0.00

0.21

0.0

1.0

—

Secondary hypertension

0.00

0.21

0.0

1.0

—

Overjet

0.00

0.21

0.0

1.0

—

Atrial septal defect, secundum type

0.00

0.21

0.0

1.0

—

Mental retardation

0.00

0.21

0.0

1.0

—

Mental retardation, wide definition

0.00

0.21

0.0

1.0

—

Congenital malformations of eye, ear, face and neck

0.00

0.21

0.0

1.0

—

Viral hepatitis, IBD co-morbidity

0.00

0.21

0.0

1.1

—

Mandibular retrognathia

0.00

0.21

0.0

1.0

—

Hypoglycaemia, other or unspecified

0.00

0.21

0.0

1.0

—

conjunctival haemorrhage

0.00

0.21

0.0

1.0

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.21

0.0

1.0

—

Crushed, pushed or stepped on by crowd or human stampede

0.00

0.21

0.0

1.0

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

0.00

0.21

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

0.00

0.21

0.0

1.0

—

Nail disorders

0.00

0.21

0.0

1.0

—

Other appendicitis

0.00

0.21

0.0

1.0

—

Smoking dependency

0.00

0.21

0.0

1.0

—

Mental and behavioural disorders due to tobacco

0.00

0.21

0.0

1.0

—

Other/unspecified enthesopathies, not elsewhere classified

0.00

0.21

0.0

1.0

—

Unspecified urinary incontinence

0.00

0.21

0.0

1.0

—

Benign neoplasm: Stomach

0.00

0.21

0.0

1.0

—

Neuromuscular dysfunction of bladder

0.00

0.21

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.21

0.0

1.0

—

Metatarsalgia

0.00

0.21

0.0

1.0

—

Graves disease, strict definition

0.00

0.21

0.0

1.0

—

Primary hyperparathyroidism

0.00

0.21

0.0

1.0

—

Abnormalities of forces of labour

0.00

0.21

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

0.21

0.0

1.0

—

Carcinoma in situ of cervix uteri

0.00

0.21

0.0

1.0

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.21

0.0

1.0

—

Diabetic neuropathy

0.00

0.21

0.0

1.2

—

Fentanyl

0.00

0.21

0.0

1.1

—

Thyroiditis, ILD-related definition

0.00

0.21

0.0

1.0

—

Thyrotoxicosis with diffuse goitre

0.00

0.21

0.0

1.0

—

Respiratory distress of newborn

0.00

0.21

0.0

1.0

—

Respiratory and cardiovascular disorders specific to the perinatal period

0.00

0.21

0.0

1.0

—

Congenital malformations of the urinary system

0.00

0.21

0.0

1.0

—

Congenital malformations of the urinary system, including avohilmo

0.00

0.21

0.0

1.0

—

Disorders of mineral metabolism

0.00

0.21

0.0

1.1

—

Stenosis and insufficiency of lacrimal passages

0.00

0.21

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

0.21

0.0

1.0

—

Seronegative rheumatoid arthritis

0.00

0.21

0.0

1.2

—

Intermittent heterotropia

0.00

0.21

0.0

1.0

—

Atrial septal defect

0.00

0.21

0.0

1.0

—

Cardiac murmurs and other cardiac sounds

0.00

0.21

0.0

1.0

—

Urticaria

1.16

0.21

1.0

—

Asthma, including avohilmo

110

1.15

0.21

1.0

—

Outcome of delivery

0.00

0.21

0.0

1.0

—

Multiple delivery

0.00

0.21

0.0

1.1

—

Abnormal results of function studies

0.00

0.21

0.0

1.0

—

Other and unspecified rosacea

0.00

0.21

0.0

1.0

—

Open wound of ankle and foot

0.00

0.21

0.0

1.0

—

Retained placenta and membranes, without haemorrhage

0.00

0.21

0.0

1.1

—

Melanocytic naevi of trunk

0.00

0.21

0.0

1.0

—

Other disorders of breast

0.00

0.21

0.0

1.0

—

Soft tissue disorders

1.17

0.20

1.0

—

Other disorders of urethra and urinary system

0.80

0.20

1.0

1.1

—

Dentofacial anomalies [including malocclusion]

1.21

0.20

1.1

1.0

—

Adalimumab

0.00

0.20

0.0

1.0

—

Chalazion

0.00

0.20

0.0

1.0

—

Otitis externa, unspecified

0.00

0.20

0.0

1.0

—

Endometriosis ASRM stages 1,2

0.00

0.20

0.0

1.0

—

Hypopituitarism

0.00

0.20

0.0

1.0

—

L02BA Anti-estrogens

0.00

0.20

0.0

1.1

—

Injuries to the ankle and foot

100

1.19

0.20

1.0

—

Non-ischemic cardiomyopathy

1.19

0.19

1.0

—

Pacemaker

1.19

0.19

1.2

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1.17

0.19

1.1

1.0

—

Other arthritis (FG)

1.18

0.19

1.0

1.1

—

Deviated nasal septum

1.17

0.19

1.0

1.1

—

All chronic kidney diseases

1.25

0.19

1.0

1.1

—

Fall on same level

111

0.86

0.19

1.1

1.0

—

Other reaction to severe stress, and adjustment disorders

1.13

0.18

1.2

1.1

—

Type 2 diabetes, wide definition

1.18

0.18

1.1

1.0

—

Dental caries, including avohilmo

1.19

0.18

1.1

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.84

0.18

1.2

1.0

—

Diaphragmatic hernia

1.19

0.18

1.0

1.1

—

Temporomandibular joint disorders, including avohilmo

1.17

0.17

1.0

1.1

—

Papulosquamous disorders

1.17

0.17

1.1

—

Insulin medication

1.20

0.17

1.1

1.0

—

Shoulder lesions

1.18

0.17

1.1

—

Degeneration of macula and posterior pole

0.73

0.17

1.0

—

Asthma, hospital admissions , main diagnosis only

112

1.16

0.17

1.0

—

Diseases of oral cavity, salivary glands and jaws

1.14

0.16

1.0

1.1

—

Conjunctivitis

1.17

0.16

1.1

1.0

—

Pregnancy with abortive outcome

0.76

0.16

1.0

—

Dorsopathies

0.86

0.16

1.0

1.1

—

COPD, hospital admissions

1.12

0.16

1.0

1.1

—

Hernia of abdominal wall

1.11

0.16

1.0

1.1

—

Disorders of skin appendages

0.77

0.15

1.0

1.1

—

Diseases of middle ear and mastoid

1.13

0.15

1.0

1.1

—

Depression

108

0.87

0.15

1.0

—

Ischaemic Stroke, excluding all haemorrhages

0.80

0.15

1.0

—

Hypothyroidism, strict autoimmune

1.17

0.14

1.1

1.0

—

Artificial joint operation, meniscal resection

0.87

0.14

1.0

1.1

—

0.83

0.14

1.3

1.0

—

Excessive attrition of teeth

0.82

0.13

1.0

1.1

—

Appendectomy

1.18

0.13

1.1

1.0

—

Spondylopathies

0.86

0.13

1.0

1.1

—

Codeine or tramadol medication

1.12

0.13

1.1

1.0

—

Diverticular disease of intestine

1.17

0.13

1.1

1.0

—

Excessive earwax

100

0.81

0.13

1.0

—

Benign neoplasms

1.13

0.12

1.0

—

Disorders of the thyroid gland

0.88

0.12

1.1

1.0

—

Hypertensive diseases

1.13

0.11

1.1

1.0

—

Rotator cuff syndrome

1.16

0.11

1.1

—

Hypertension

1.13

0.11

1.1

1.0

—

Other retinal disorders

1.16

0.11

1.1

1.0

—

Other diseases of upper respiratory tract

104

0.90

0.11

1.0

—

Spondylosis

1.17

0.11

1.0

1.1

—

Insulin, intermediate and long-acting

1.16

0.10

1.1

1.0

—

Cerebrovascular diseases

1.13

0.10

1.1

1.0

—

Benign thyroid growths and nodules

1.13

0.10

1.2

1.0

—

Transport accidents

1.16

0.10

1.1

1.0

—

Artrosis, including avohilmo

0.89

0.10

1.0

—

Inflammatory bowel disease

1.11

0.09

1.0

1.1

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.11

0.09

1.0

1.1

—

Arthrosis

1.13

0.09

1.0

1.1

—

Keratitis

1.04

0.09

1.0

—

Accidents

1.11

0.09

1.1

1.0

—

Polyarthropathies

1.13

0.09

1.0

1.1

—

COPD, hospital admission 2, with asthma infections

1.02

0.09

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.10

0.09

1.2

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1.10

0.09

1.0

—

Myocardial infarction, without ST-elevation

1.10

0.09

1.0

1.1

—

Abrasion of teeth

1.11

0.09

1.2

1.1

—

Other neurological diseases

1.12

0.09

1.0

1.1

—

Other disorders of veins

1.09

0.09

1.0

1.1

—

Hernia

103

0.90

0.08

1.1

1.0

—

1.06

0.08

1.0

1.1

—

Cervical disc disorders

1.03

0.08

1.0

1.1

—

Extrapyramidal and movement disorders

0.81

0.08

1.0

—

Myocardial infarction

1.04

0.08

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

1.09

0.08

1.1

1.0

—

Complications of labour and delivery

0.81

0.08

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.04

0.08

1.1

—

Episodal and paroxysmal disorders

0.92

0.08

1.0

1.1

—

Urinary track infection

1.05

0.07

1.0

1.1

—

Disorders of vestibular function (Vertigo)

0.82

0.07

1.2

1.0

—

Diseases of the musculoskeletal system and connective tissue

1.14

0.07

1.0

1.1

—

Varicose veins

0.87

0.07

1.1

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

0.85

0.07

1.1

1.0

—

Diseases of inner ear

0.85

0.07

1.1

—

Alcohol use disorder, Swedish definition

0.84

0.07

1.3

1.0

—

Reimbursement for rheumatic diseases

0.83

0.07

1.0

1.1

—

Dizziness and giddiness

1.10

0.07

1.1

1.0

—

Used for control exclusion in common control thyroid runs

0.92

0.07

1.1

1.0

—

Glaucoma

1.05

0.07

1.1

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.04

0.07

1.1

1.0

—

Statin medication

0.90

0.07

1.0

—

Benign neoplasm: Colon

1.03

0.07

1.0

—

Mood disorders, excluding more controls

0.91

0.07

1.0

—

Diseases of pulp and periapical tissues and dental caries

0.89

0.06

1.0

—

Ischemic heart diseases

1.09

0.06

1.1

1.0

—

Senile cataract

1.10

0.06

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

1.07

0.05

1.1

1.0

—

Symptoms and signs involving the urinary system

1.09

0.05

1.1

1.0

—

Diseases of male genital organs

1.12

0.05

1.0

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

108

0.93

0.05

1.1

1.0

—

Use of hypnotics and sedatives

102

1.06

0.04

1.1

1.0

—

Anxiety disorders, excluding more controls

1.08

0.04

1.1

1.0

—

Genitourinary diseases

1.09

0.04

1.0

1.1

—

Ischaemic heart disease, wide definition

1.08

0.04

1.2

1.0

—

Major coronary heart disease event excluding revascularizations

1.10

0.04

1.2

1.0

—

Stroke, excluding SAH

1.09

0.03

1.1

1.0

—

Hard cardiovascular diseases

1.05

0.02

1.1

1.0

—

Other joint disorders

0.95

0.01

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.05

0.01

1.1

1.0

—

Other specific joint derangements/joint disorders

0.94

0.01

1.0

1.1

—

Disorders of conjunctiva

103

1.05

0.01

1.1

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.05

0.01

1.0

—

Other external causes of accidental injury

1.04

0.00

1.1

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

0.96

0.00

1.1

1.0

—

Major coronary heart disease event

1.01

0.00

1.1

1.0

—

Stroke, including SAH

1.00

0.00

1.1

1.0

—

Injuries to the wrist and hand

112

1.01

0.00

1.1

1.0

—

Asthma/COPD (KELA code 203)

104

1.03

0.00

1.0

—

Other disorders of skin and subcutaneous tissue

1.02

0.00

1.0

1.1

—

Autoimmune diseases related-to ILD

109

1.00

0.00

1.1

1.0

—

Any mental disorder

0.97

0.00

1.1

1.0

—

Autoimmune diseases

1.00

0.00

1.2

1.0

—

Biguanides

1.01

0.00

1.1

1.0

—

Percutaneous Coronary Intervention

0.99

0.00

1.1

1.0

—

Hypothyroidism, other/unspecified

0.99

0.00

1.1

1.0

—

Selective serotonin reuptake inhibitors

1.00

0.00

1.1

1.0

—

Coronary revascularization (ANGIO or CABG)

0.99

0.00

1.1

1.0

—

Enterobiasis, including avohilmo

0.00

0.0

1.0

—

Fracture of forearm

0.96

0.00

1.3

1.0

—

Other contact dermatitis

0.00

0.0

1.0

—

Vascular syndromes of brain in cerebrovascular disorders

0.00

0.0

1.0

—

Glucosamine medication

0.94

0.00

1.0

1.1

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.0

—

Other peripheral vascular diseases

0.00

0.0

1.0

—

Myocardial infarction, strict

0.92

0.00

1.0

—

Left bundle-branch block

0.00

0.0

1.0

—

Foreign body or object entering through skin

0.00

0.0

1.0

—

Acetic acid derivatives and related substances

1.03

0.00

1.0

1.1

—

Glucagon-like peptide-1 (GLP-1) analogues

0.98

0.00

1.0

1.1

—

Mental and behavioural disorders due to sedatives or hypnotics

0.00

0.0

1.0

—

Antepartum haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Eustachian salpingitis and obstruction

0.00

0.0

1.0

—

Cerebral palsy

0.00

0.0

1.0

—

Hypermobility syndrome

0.00

0.0

1.0

—

Alcohol-induced chronic pancreatitis

0.00

0.0

1.0

—

Memory loss

0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.0

1.0

—

Glaucoma, exfoliation

0.00

0.0

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

0.98

0.00

1.0

1.1

—

Allergic colitis

0.00

0.0

1.0

—

Faecal incontinence

0.00

0.0

1.0

—

Congenital malformations of the respiratory system

0.00

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

0.0

1.0

—

Dialysis

0.00

0.0

1.0

—

Asthma and allergy, excluding more controls

0.00

0.0

1.0

—

Dermatographic urticaria

0.00

0.0

1.0

—

Other specified congenital malformation syndromes affecting multiple systems

0.00

0.0

1.0

—

Other juvenile arthritis

0.00

0.0

1.0

—

Other and unspecified drugs and medicaments

0.00

0.0

1.0

—

Contact with other sharp object(s)

0.00

0.0

1.0

—

Other and unspecified disorders of psychological development

0.00

0.0

1.0

—

Other disorders originating in the perinatal period

0.00

0.0

1.0

—

Nephrotic syndrome

0.00

0.0

1.0

—

Congenital malformations of pulmonary and tricuspid valves

0.00

0.0

1.0

—

Demyelinating diseases of the central nervous system

0.00

0.0

1.0

—

Hyperlipidaemia, other/unspecified

1.02

0.00

1.0

—

Amblyopia ex anopsia

0.00

0.0

1.0

—

Cystic kidney disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Care involving dialysis

0.00

-0.00

0.0

1.0

—

Fibromyalgia

0.00

-0.00

0.0

1.0

—

Respiratory insufficiency

0.00

-0.00

0.0

1.0

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

1.0

—

Event of undetermined intent

0.00

-0.00

0.0

1.0

—

Other and unspecified mental retardation

0.00

-0.00

0.0

1.0

—

Panniculitis affecting regions of neck and back

0.00

-0.00

0.0

1.0

—

Malnutrition

0.00

-0.00

0.0

1.0

—

Myocarditis

0.00

-0.00

0.0

1.0

—

Chromosomal abnormalities, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Schizoaffective disorder

0.00

-0.00

0.0

1.0

—

Skin changes due to chronic exposure to nonionizing radiation

0.94

-0.00

1.0

1.1

—

Lactose intolerance

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

!Aliquae complicationes praecoces traumatis

0.00

-0.00

0.0

1.0

—

Symptoms and signs involving emotional state

0.00

-0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP)

0.00

-0.00

0.0

1.0

—

Trigeminal neuralgia

0.00

-0.00

0.0

1.0

—

Congenital musculoskeletal deformities of head, face, spine and chest, including avohilmo

0.00

-0.00

0.0

1.0

—

Abnormal findings on antenatal screening of mother

0.00

-0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.0

—

Nutritional anaemias

0.93

-0.00

1.0

1.1

—

Cerebral aneurysm, nonruptured

0.00

-0.00

0.0

1.0

—

Hyperfunction of pituitary gland

0.00

-0.00

0.0

1.0

—

Anisometropia and aniseikonia

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Dermatophytosis, including avohilmo

0.91

-0.00

1.0

—

Hemiplegia

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Acidosis

0.00

-0.00

0.0

1.0

—

STROKE

0.99

-0.00

1.1

1.0

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Foreign body in respiratory tract

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases

0.00

-0.00

0.0

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

0.00

-0.00

0.0

1.0

—

Gonarthrosis

0.91

-0.00

1.0

1.1

—

Torsion of ovary, ovarian pedicle and fallopian tube

0.00

-0.00

0.0

1.0

—

Postpartum care and examination

0.00

-0.00

0.0

1.0

—

Persons encountering health services in other circumstances

0.96

-0.00

1.0

1.1

—

Other dialysis

0.00

-0.00

0.0

1.0

—

Preparatory care for dialysis

0.00

-0.00

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

-0.00

0.0

1.0

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS